{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:24:50Z","timestamp":1769941490118,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"U.S. Agency for International Development (USAID) through the Latin American and the Caribbean Regional Malaria Program"},{"name":"Colombian National Institute of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Resistance to anti-malarial drugs is associated with polymorphisms in target genes and surveillance for these molecular markers is important to detect the emergence of mutations associated with drug resistance and signal recovering sensitivity to anti-malarials previously used.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The presence of polymorphisms in genes associated with <jats:italic>Plasmodium falciparum<\/jats:italic> resistance to chloroquine and sulfadoxine-pyrimethamine was evaluated by Sanger sequencing, in 85 <jats:italic>P. falciparum<\/jats:italic> day of enrollment samples from a therapeutic efficacy study of artemether\u2013lumefantrine conducted in 2018\u20132019 in Quibdo, Colombia. Samples were genotyped to assess mutations in <jats:italic>pfcrt<\/jats:italic> (codons 72\u201376), <jats:italic>pfdhfr<\/jats:italic> (codons 51, 59, 108, and 164), and <jats:italic>pfdhps<\/jats:italic> genes (codons 436, 437, 540, and 581). Further, the genetic diversity of infections using seven neutral microsatellites (NMSs) (C2M34, C3M69, Poly \u03b1, TA1, TA109, 2490, and PfPK2) was assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All isolates carried mutant alleles for <jats:italic>pfcrt (<\/jats:italic>K76<jats:bold>T<\/jats:bold> and N75<jats:bold>E)<\/jats:bold><jats:italic>,<\/jats:italic> and for <jats:italic>pfdhfr<\/jats:italic> (N51<jats:bold>I<\/jats:bold> and S108<jats:bold>N)<\/jats:bold>, while for <jats:italic>pfdhps<\/jats:italic>, mutations were observed only for codon A437<jats:bold>G<\/jats:bold> (32\/73, 43.8%). Fifty samples (58.8%) showed a complete neutral microsatellites (NMS) profile. The low mean number of alleles (2\u00a0\u00b1\u00a00.57)\u00a0per locus and mean expected heterozygosity (0.17\u00a0\u00b1 0.03) showed a reduced genetic diversity. NMS multilocus genotypes (MMG) were built and nine MMG were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, these findings confirm the fixation of chloroquine and pyrimethamine-resistant alleles already described in the literature, implying that these drugs are not currently appropriate for use in Colombia. In contrast, mutations in the <jats:italic>pfdhps<\/jats:italic> gene were only observed at codon 437, an indication that full resistance to sulfadoxine has not been achieved in Choco. MMGs found matched the clonal lineage E variant 1 previously reported in northwestern Colombia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04328-x","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T18:02:57Z","timestamp":1666980177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018"],"prefix":"10.1186","volume":"21","author":[{"given":"Angela Patricia","family":"Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Javier","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Jazm\u00edn","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella M.","family":"Chenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Macedo de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi W.","family":"Lucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"4328_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247811","volume":"16","author":"JC Padilla-Rodr\u00edguez","year":"2021","unstructured":"Padilla-Rodr\u00edguez JC, Olivera MJ, Ahumada-Franco ML, Paredes-Medina AE. Malaria risk stratification in Colombia 2010 to 2019. PLoS ONE. 2021;16: e0247811.","journal-title":"PLoS ONE"},{"key":"4328_CR2","unstructured":"WHO. World malaria report 2019. Geneva, World Health Organization, 2019. https:\/\/www.who.int\/publications\/i\/item\/world-malaria-report-2019. Accessed 3 Nov 2021."},{"key":"4328_CR3","unstructured":"WHO. World malaria report 2020. Geneva, World Health Organization, 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240015791. Accessed 3 Nov 2021."},{"key":"4328_CR4","unstructured":"Ferro C, Sastoque LA. Informe del evento malaria, Colombia 2019. Instituto Nacional de Salud. http:\/\/www.ins.gov.co\/buscador-eventos\/Informesdeevento\/MALARIA%20PE%20XIII%202019.pdf. Accessed 9 Nov 2021."},{"key":"4328_CR5","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4269\/ajtmh.1999.61.968","volume":"61","author":"LE Osorio","year":"1999","unstructured":"Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK, et al. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. Am J Trop Med Hyg. 1999;61:968\u201372.","journal-title":"Am J Trop Med Hyg"},{"key":"4328_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2875-5-14","volume":"5","author":"S Blair","year":"2006","unstructured":"Blair S, Carmona-Fonseca J, Pi\u00f1eros JG, R\u00edos A, Alvarez T, Alvarez G, et al. Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malar J. 2006;5:14.","journal-title":"Malar J"},{"key":"4328_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7705\/biomedica.v27i1.239","volume":"27","author":"L Osorio","year":"2007","unstructured":"Osorio L, Perez LDP, Gonzalez IJ. Assessment of the efficacy of antimalarial drugs in Tarapaca, in the Colombian Amazon basin. Biomedica. 2007;27:133\u201340.","journal-title":"Biomedica"},{"key":"4328_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2958.2005.04556.x","volume":"56","author":"PG Bray","year":"2005","unstructured":"Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol. 2005;56:323\u201333.","journal-title":"Mol Microbiol"},{"key":"4328_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/pr.57.1.4","volume":"57","author":"A Gregson","year":"2005","unstructured":"Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117\u201345.","journal-title":"Pharmacol Rev"},{"key":"4328_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4269\/ajtmh.19-0954","volume":"102","author":"MJ Olivera","year":"2020","unstructured":"Olivera MJ, Guerra AP, Cortes LJ, Horth RZ, Padilla J, Novoa J, et al. Artemether\u2013lumefantrine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Choco, Colombia after 8 years as first-line treatment. Am J Trop Med Hyg. 2020;102:1056\u201363.","journal-title":"Am J Trop Med Hyg"},{"key":"4328_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056677","volume":"8","author":"NW Lucchi","year":"2013","unstructured":"Lucchi NW, Narayanan J, Karell MA, Xayavong M, Kariuki S, DaSilva AJ, et al. Molecular diagnosis of malaria by photo-induced electron transfer fluorogenic primers: PET-PCR. PLoS ONE. 2013;8: e56677.","journal-title":"PLoS ONE"},{"key":"4328_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/AAC.01243-09","volume":"54","author":"S Griffing","year":"2010","unstructured":"Griffing S, Syphard L, Sridaran S, McCollum AM, Mixson-Hayden T, Vinayak S, et al. pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother. 2010;54:1572\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"4328_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1086\/504687","volume":"194","author":"AM McCollum","year":"2006","unstructured":"McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis. 2006;194:189\u201397.","journal-title":"J Infect Dis"},{"key":"4328_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000830","volume":"6","author":"S Vinayak","year":"2010","unstructured":"Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, Shah NK, et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog. 2010;6: e1000830.","journal-title":"PLoS Pathog"},{"key":"4328_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/S0031182099004552","volume":"119","author":"TJ Anderson","year":"1999","unstructured":"Anderson TJ, Su XZ, Bockarie M, Lagog M, Day KP. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology. 1999;119:113\u201325.","journal-title":"Parasitology"},{"key":"4328_CR16","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/molbev\/msg162","volume":"20","author":"S Nair","year":"2003","unstructured":"Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, et al. A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol Biol Evol. 2003;20:1526\u201336.","journal-title":"Mol Biol Evol"},{"key":"4328_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(03)12951-0","volume":"361","author":"C Roper","year":"2003","unstructured":"Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet. 2003;361:1174\u201381.","journal-title":"Lancet"},{"key":"4328_CR18","first-page":"1153","volume":"272","author":"D Nash","year":"2005","unstructured":"Nash D, Nair S, Mayxay M, Newton PN, Guthmann JP, Nosten F, et al. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci. 2005;272:1153\u201361.","journal-title":"Proc Biol Sci"},{"key":"4328_CR19","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1128\/AAC.00036-10","volume":"54","author":"V Corredor","year":"2010","unstructured":"Corredor V, Murillo C, Echeverry DF, Benavides J, Pearce RJ, Roper C, et al. Origin and dissemination across the Colombian Andes Mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2010;54:3121\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"4328_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12936-015-0887-9","volume":"14","author":"SM Chenet","year":"2015","unstructured":"Chenet SM, Taylor JE, Blair S, Zuluaga L, Escalante AA. Longitudinal analysis of Plasmodium falciparum genetic variation in Turbo, Colombia: implications for malaria control and elimination. Malar J. 2015;14:363.","journal-title":"Malar J"},{"key":"4328_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163137","volume":"11","author":"EJ Dorado","year":"2016","unstructured":"Dorado EJ, Okoth SA, Montenegro LM, Diaz G, Barnwell JW, Udhayakumar V, et al. Genetic characterisation of Plasmodium falciparum isolates with deletion of the pfhrp2 and\/or pfhrp3 genes in Colombia: the Amazon region, a challenge for malaria diagnosis and control. PLoS ONE. 2016;11: e0163137.","journal-title":"PLoS ONE"},{"key":"4328_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023486","volume":"6","author":"SM Griffing","year":"2011","unstructured":"Griffing SM, Mixson-Hayden T, Sridaran S, Alam MT, McCollum AM, Cabezas C, et al. South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS ONE. 2011;6: e23486.","journal-title":"PLoS ONE"},{"key":"4328_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12936-015-1019-2","volume":"14","author":"FE S\u00e1enz","year":"2015","unstructured":"S\u00e1enz FE, Morton LC, Okoth SA, Valenzuela G, Vera-Arias CA, V\u00e9lez-\u00c1lvarez E, et al. Clonal population expansion in an outbreak of Plasmodium falciparum on the northwest coast of Ecuador. Malar J. 2015;14:497.","journal-title":"Malar J"},{"key":"4328_CR24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4269\/ajtmh.2007.77.1034","volume":"77","author":"DF Echeverry","year":"2007","unstructured":"Echeverry DF, Holmgren G, Murillo C, Higuita JC, Bj\u00f6rkman A, Gil JP, et al. Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am J Trop Med Hyg. 2007;77:1034\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"4328_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/trstmh\/trx021","volume":"111","author":"S Aponte","year":"2017","unstructured":"Aponte S, Guerra AP, \u00c1lvarez-Larrotta C, Bernal SD, Restrepo C, Gonz\u00e1lez C, et al. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia. Trans R Soc Trop Med Hyg. 2017;111:71\u201380.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4328_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.17843\/rpmesp.2014.312.47","volume":"31","author":"N Arr\u00f3spide","year":"2014","unstructured":"Arr\u00f3spide N, Hijar-Guerra G, de Mora D, Diaz-Cort\u00e9z CE, Veloz-P\u00e9rez R, Guti\u00e9rrez S, et al. Mutant alleles associated to chloroquine and sulfadoxine-pyrimethanime resistance in Plasmodium falciparum of the Ecuador-Peru and Ecuador-Colombia borders. Rev Peru Med Exp Salud Publica. 2014;31:282\u20137.","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"4328_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12936-019-3044-z","volume":"18","author":"G Valenzuela","year":"2019","unstructured":"Valenzuela G, Castro LE, Valencia-Zamora J, Vera-Arias CA, Rohrbach P, S\u00e1enz FE. Genotypes and phenotypes of resistance in Ecuadorian Plasmodium falciparum. Malar J. 2019;18:415.","journal-title":"Malar J"},{"key":"4328_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4269\/ajtmh.2003.68.413","volume":"68","author":"T Mita","year":"2003","unstructured":"Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg. 2003;68:413\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"4328_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1086\/655659","volume":"202","author":"MK Laufer","year":"2010","unstructured":"Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801\u20138.","journal-title":"J Infect Dis"},{"key":"4328_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7705\/biomedica.v30i1.153","volume":"30","author":"JA Galindo","year":"2010","unstructured":"Galindo JA, Knudson A, Nicholls RS, Guerra AP. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum from three endemic malaria regions in Colombia. Biomedica. 2010;30:56\u201364.","journal-title":"Biomedica"},{"key":"4328_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.meegid.2013.05.017","volume":"18","author":"DC Hern\u00e1ndez","year":"2013","unstructured":"Hern\u00e1ndez DC, Guerra AP, Cucunub\u00e1 ZM, Nicholls RS, Barrera SM. Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia. Infect Genet Evol. 2013;18:183\u201390.","journal-title":"Infect Genet Evol"},{"key":"4328_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S0031182008004307","volume":"135","author":"E Restrepo-Pineda","year":"2008","unstructured":"Restrepo-Pineda E, Arango E, Maestre A, Do Ros\u00e1rio VE, Cravo P. Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt. Parasitology. 2008;135:547\u201353.","journal-title":"Parasitology"},{"key":"4328_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7705\/biomedica.v28i4.57","volume":"28","author":"E Restrepo","year":"2008","unstructured":"Restrepo E, Carmona-Fonseca J, Maestre A. Plasmodium falciparum: high frequency of pfcrt point mutations and emergence of new mutant haplotypes in Colombia. Biomedica. 2008;28:523\u201330.","journal-title":"Biomedica"},{"key":"4328_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12936-020-03247-z","volume":"19","author":"MA Pacheco","year":"2020","unstructured":"Pacheco MA, Forero-Pe\u00f1a DA, Schneider KA, Chavero M, Gamardo A, Figuera L, et al. Malaria in Venezuela: changes in the complexity of infection reflects the increment in transmission intensity. Malar J. 2020;19:176.","journal-title":"Malar J"},{"key":"4328_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4269\/ajtmh.18-0515","volume":"100","author":"G Diaz","year":"2019","unstructured":"Diaz G, Lasso AM, Murillo C, Montenegro LM, Echeverry DF. Evidence of self-medication with chloroquine before consultation for malaria in the Southern Pacific Coast Region of Colombia. Am J Trop Med Hyg. 2019;100:66\u201371.","journal-title":"Am J Trop Med Hyg"},{"key":"4328_CR36","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1073\/pnas.221440898","volume":"98","author":"RK Mehlotra","year":"2001","unstructured":"Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, et al. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA. 2001;98:12689\u201394.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04328-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T18:03:48Z","timestamp":1666980228000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04328-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4328"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04328-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TES protocol was reviewed and approved by the Institutional Ethics Committee of the Colombian National Institute of Health (Protocol CEMIN 2-2018, Minute #5 of March 22, 2018) and the PAHO Ethics Review Committee (PAHOERC) (PAHO 2018-04-0029). CDC considered the study a public health evaluation (reference number: 2018-063).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}